docosyltrimethylammonium methyl sulphate CAS: 81646-13-1

CAS NO: 81646-13-1
docosyltrimethylammonium methyl sulphate
Chemical Name: docosyltrimethylammonium methyl sulphate
Molecular Formula: C26H57NO4S
Formula Weight: 479.81
CAS No.: 81646-13-1
Description Review
Description

Docosyltrimethylammonium methyl sulphate is a quaternary ammonium compound, also known as DTAC or DTTMS. It is an organic salt and classified as a cationic surfactant. The molecular formula of DTAC is C25H54NCH3SO4, and its formula weight is 507.79 g/mol. The CAS number for DTAC is 81646-13-1.

DTAC has various applications in the field of cosmetics, drug delivery systems, and pharmaceuticals. It is used as a preservative, emulsifier, and antimicrobial agent in several cosmetic products. In this article, we will explore the different aspects of DTAC, including health benefits, potential effects, product mechanism, safety, side effects, and dosing information.

Top Ten Keywords from Google and Synonyms:

  1. Quaternary Ammonium Compound
  2. Cationic Surfactant
  3. Antimicrobial Agent
  4. Preservative
  5. Emulsifier
  6. DTAC
  7. DTTMS
  8. Organic Salt
  9. Molecular Formula
  10. CAS Number

Other synonyms for DTAC include Docosyltrimethylammonium Methylsulfate, N,N-Docosyl-N,N-dimethyl-1-propanaminium methyl sulfate, and Trimethyl(docosyl)ammonium methyl sulfate.

Health Benefits of DTAC:

DTAC has several health benefits due to its antimicrobial properties. It is effective against a wide range of microorganisms, including bacteria, fungi, and viruses. DTAC disrupts the cell membrane of microorganisms, leading to their death.

DTAC is commonly used in pharmaceuticals to improve the efficacy of drug delivery systems. It enhances the absorption of drugs by increasing their solubility and stability. DTAC also enhances the penetration of drugs through the skin.

Potential Effects:

DTAC has several potential effects, both positive and negative. Its antimicrobial properties make it useful in preventing infections and preserving cosmetic products. It is also effective in improving the absorption of drugs, which can lead to more effective treatments. However, overuse of DTAC can lead to resistance among microorganisms, making it less effective over time.

Product Mechanism:

DTAC works by disrupting the cell membrane of microorganisms. It is attracted to the negatively charged surface of the cell membrane, where it binds to the phospholipid head groups. This leads to the disruption of the lipid bilayer, causing leakage of cellular contents and ultimately the death of the microorganism.

Safety:

DTAC is generally considered safe when used in appropriate amounts. However, excessive use can lead to skin irritation, allergic reactions, and respiratory problems. DTAC should not be ingested or applied to open wounds.

Side Effects:

The most common side effect of DTAC is skin irritation. This can manifest as redness, itching, and swelling. In rare cases, DTAC can cause allergic reactions, including hives, difficulty breathing, and anaphylaxis. If these symptoms occur, medical attention should be sought immediately.

Dosing Information:

DTAC is used in a variety of concentrations, depending on its intended application. For cosmetic products, DTAC is typically used at concentrations of 0.5-5%. Higher concentrations may cause skin irritation. In drug delivery systems, the concentration of DTAC varies depending on the specific drug being delivered.

Conclusion:

Docosyltrimethylammonium methyl sulphate is a versatile compound with numerous applications in cosmetics, drug delivery systems, and pharmaceuticals. Its antimicrobial properties make it effective in preventing infections and preserving cosmetic products. DTAC enhances the absorption of drugs, making them more effective. While generally safe when used appropriately, excessive use can lead to skin irritation and allergic reactions. As with any chemical compound, caution should be exercised when handling DTAC, and appropriate safety measures should be taken.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code